CClinicalTrials.gg
Active, not recruitingNCT05275192Updated Aug 17, 2026

Utilization of a Videoscope in Periodontal Regeneration

An interventional study of Videoscope-assisted periodontal regeneration minimally invasive surgery and Periodontal regeneration minimally invasive surgery in Chronic Periodontitis, sponsored by University of Illinois at Chicago. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Clinical and preclinical studies confirm that regeneration of supporting tissues of teeth lost due to periodontal disease can be achieved using the principles of minimally invasive surgery (MIS). Although this therapeutic approach is well established in clinical settings and can rescue teeth with poor or questionable prognosis, MIS approaches often suffer from lack of predictability due to poor intraoral visibility of the bony lesion and inability to confirm thorough removal of etiological factors (plaque/calculus) on tooth surfaces. We seek to investigate whether improved visualization of the surgical field using an FDA approved videoscope (V) improves clinical outcomes. For this pilot study, N=50 (to attain 10/group) age, sex matched, systemically healthy subjects diagnosed with Stage III, Grade B periodontitis, formerly known as severe chronic periodontitis, will be randomly assigned to either the VMIS (Test), MIS (Control 1) or Guided Tissue Regeneration (GTR, Control 2) group. All periodontal therapy will be performed following the Standard of Care for periodontal regeneration to determine if utilization of the videoscope improves clinical and radiographic outcomes. We will examine bone fill using conventional digital periapical radiographs (PAR) and Cone Beam Computed Tomography (CBCT) imaging at 6 and 12 months compared to baseline and collect gingival crevicular fluid (GCF) to compare expression of growth factors and cytokines/chemokines during the healing period. This is a single center treatment study where subjects will be recruited from individuals seeking periodontal treatment at the Graduate Periodontics Clinic, UIC College of Dentistry (COD). Participation of all subjects will end after 12 months and will comprise 7 total visits.

02

Conditions studied

  • Chronic Periodontitis

Keywords

  • Periodontitis
  • Minimally invasive surgery
  • Videoscope
  • Guided tissue regeneration
  • Stage III, Grade B periodontitis
03

In context

Chronic Periodontitis

378 studies on the registry are indexed under Chronic Periodontitis; 23 are open to participants now.

This study's planned enrollment of 50 is above the median of 45 across 307 interventional studies indexed under Chronic Periodontitis.

Browse Chronic Periodontitis studies →

Lead sponsor

University of Illinois at Chicago is the lead sponsor of 515 studies on the registry; 133 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 18 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

    • Individual must be between the age of 18 and 70 years of age

      • ASA I or II systemically healthy subjects
      • Individuals presenting with at least 1 single or multirooted tooth with residual, isolated, interproximal bony defect with probing depths (PD) ≥ 6 mm, clinical attachment loss (CAL) ≥ 6mm, bleeding upon probing (BOP), and ≥ 2mm width of attached gingiva (WAG)
      • Radiographic evidence of interproximal alveolar bone loss, on existing (\< 2 years old) dental radiographs of diagnostic quality taken at the COD
      • Vital tooth or previous root canal therapy with no signs/symptoms of pathology
      • Individuals with plaque scores ≤ 20%
      • English speaking subjects (Individual must be willing to follow all the study requirements and participate in the study procedures in its entirety and read, understand the informed consent form)

Exclusion criteria

Exclusion Criteria:

  • Individuals not referred from the Predoctoral Periodontics Student Clinics

    • Uncontrolled systemic disorders such as hypertension, heart disease, bleeding disorders, metabolic bone diseases, autoimmune disorders, etc., that may influence cellular/healing status
    • Diabetics
    • Current smokers
    • Individual less than 18 years of age
    • Individuals with non-isolated, interproximal PD ≥ 4 mm extending to the facial/buccal and/or palatal/lingual tooth surfaces
    • Teeth with Grade 2 or 3 mobility
    • Teeth with metal restorations such as a porcelain fused to metal crown (due to scattering of radiographic images)
    • Intrabony defects on dental implants
    • Individual who take medications known to affect host immunity or periodontal tissues (ex. steroids, antibiotics, phenytoin, etc.) in the previous 6 months
    • Individuals on chronic anti-platelet/anti-coagulant therapy
    • Oral pathologies other than periodontal disease (ex. periapical lesions of non-periodontal origin)
    • Subjects who may be pregnant based on a positive pregnancy test
    • Non-English speaking individuals
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Videoscope-assisted periodontal regeneration minimally invasive surgery

    Videoscope-assisted periodontal regeneration minimally invasive surgery - Test group

    Device: Videoscope-assisted periodontal regeneration minimally invasive surgery

  • Active comparator
    Periodontal regeneration minimally invasive surgery

    Periodontal regeneration minimally invasive surgery - Control Group 1

    Procedure: Periodontal regeneration minimally invasive surgery

  • Active comparator
    Guided tissue regeneration surgery

    Guided tissue regeneration - Control Group 2

    Procedure: Guided tissue regeneration surgery

Interventions

  • DeviceVideoscope-assisted periodontal regeneration minimally invasive surgery

    Use of a videoscope to improve visualization of periodontal defect during minimally invasive surgery

  • ProcedurePeriodontal regeneration minimally invasive surgery

    Conventional periodontal regeneration minimally invasive surgery without use of a videoscope

  • ProcedureGuided tissue regeneration surgery

    Conventional guided tissue regeneration surgery for periodontal regeneration without use of a videoscope

06

What researchers measure

Primary outcomes

  1. Clinical Attachment Level

    Measured in mm as the periodontal probing depth (PD) plus gingival recession (GR).

    Time frame: 6 months

  2. Probing Depth (PD)

    Measured in mm as the distance from the gingival margin (GM) to the base of the gingival sulcus.

    Time frame: 6 months

  3. Gingival Recession (GR)

    Measured in mm as distance of the gingival margin (GM) to the cemento-enamel junction (CEJ).

    Time frame: 6 months

  4. Radiographic Bone Height (RBH)

    Measured in mm as the distance from the cemento-enamel junction (CEJ) to the base of the alveolar bone defect (ABD).

    Time frame: 6 months

  5. Radiographic Bone Volume (RBV)

    Measured in cubic mm as the volume of bone from the alveolar crest (AC) to the base of the alveolar bone defect (ABD).

    Time frame: 6 months

  6. Clinical Attachment Level

    Measured in mm as the periodontal probing depth (PD) plus gingival recession (GR).

    Time frame: 12 months

  7. Probing Depth (PD)

    Measured in mm as the distance from the gingival margin (GM) to the base of the gingival sulcus.

    Time frame: 12 months

  8. Gingival Recession (GR)

    Measured in mm as distance of the gingival margin (GM) to the cemento-enamel junction (CEJ).

    Time frame: 12 months

  9. Radiographic Bone Height (RBH)

    Measured in mm as the distance from the cemento-enamel junction (CEJ) to the base of the alveolar bone defect (ABD).

    Time frame: 12 months

  10. Radiographic Bone Volume (RBV)

    Measured in cubic mm as the volume of bone from the alveolar crest (AC) to the base of the alveolar bone defect (ABD).

    Time frame: 12 months

Secondary outcomes

  1. Gingival Crevicular Fluid (GCF) Growth Factor and Cytokine/Chemokine Levels

    Concentration of 24 cytokines, chemokines, and growth factors in gingival crevicular fluid (GCF) measured in pg/mL.

    Time frame: 6 months

  2. Gingival Crevicular Fluid (GCF) Growth Factor and Cytokine/Chemokine Levels

    Concentration of 24 cytokines, chemokines, and growth factors in gingival crevicular fluid (GCF) measured in pg/mL.

    Time frame: 12 months

07

Study locations

1 site
  • University of Illinois, Chicago, College of Dentistry, Periodontics
    Chicago, Illinois 60612, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05275192
Lead sponsor
University of Illinois at Chicago
Responsible party
Salvador Nares, DDS, MS, PHD, MBA (Professor and Department Head, University of Illinois at Chicago) — Principal investigator
First posted
Mar 11, 2022
Start date
May 1, 2022
Primary completion
Apr 30, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Aug 17, 2026

Study contacts

Salvador Nares, DDS, PhD
principal investigator · University of Illinois at Chicago

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion